U 88204

structure given in first source

Also Known As:

1-(3-(1-isopropylamino)-2-pyridinyl)-4-((1-H-indol-2-yl)carbonyl)piperazine; U-88204; U-88204E; Piperazine, 1-(1H-indol-2-ylcarbonyl)-4-(3-((1-methylethyl)amino)-2-pyridinyl)-

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Piperazines: 26
    - U 88204: 2
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indoles: 200
      - U 88204: 2

Related Diseases

Infections

09/01/1992 - "The results presented here suggest the therapeutic potential of U-88204 in the combination therapy for HIV-1 infection."
12/01/1994 - "Moreover, quinoxaline S-2720 totally prevented HIV-1 infection and emergence of drug-resistant mutant virus strains in CEM cell cultures at concentrations (i.e., 0.35 microM) that are 10- to 25-fold lower than those required for BHAP U-88204 and nevirapine to knock out the virus. "

Related Drugs and Biologics

1.	Nevirapine (Viramune)
2.	Quinoxalines
3.	S 2720

Related Therapies and Procedures

1.	Therapeutics